Extended EudraVigilance medicinal product dictionary (XEVMPD) training course for sponsors - October 2024, Online, from 10 October 2024 to 11 October 2024

Submitted by Anonymous (not verified) on 27 June 2024 - 14:40

Extended EudraVigilance medicinal product dictionary (XEVMPD) training course for sponsors - October 2024, Online, from 10 October 2024 to 11 October 2024

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2024, Online, from 18 November 2024 to 20 November 2024

Submitted by Anonymous (not verified) on 27 June 2024 - 14:38

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2024, Online, from 18 November 2024 to 20 November 2024

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2024, Online, from 22 October 2024 to 24 October 2024

Submitted by Anonymous (not verified) on 27 June 2024 - 14:37

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2024, Online, from 22 October 2024 to 24 October 2024

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - September 2024, Online, from 10 September 2024 to 12 September 2024

Submitted by Anonymous (not verified) on 27 June 2024 - 14:35

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - September 2024, Online, from 10 September 2024 to 12 September 2024

Clinical Trials Information System (CTIS): Walk-in clinic - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2024, 16:00 (CEST) to 18 September 2024, 17:00 (CEST)

Submitted by Anonymous (not verified) on 27 June 2024 - 14:07

Clinical Trials Information System (CTIS): Walk-in clinic - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2024, 16:00 (CEST) to 18 September 2024, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Cinacalcet Accordpharma, cinacalcet, Date of authorisation: 03/04/2020, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 27 June 2024 - 13:56

Human medicines European public assessment report (EPAR): Cinacalcet Accordpharma, cinacalcet, Date of authorisation: 03/04/2020, Revision: 4, Status: Authorised

Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use

Submitted by Anonymous (not verified) on 27 June 2024 - 12:53

Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use

Orphan designation: monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E (brentuximab vedotin) Treatment of Hodgkin's lymphoma, 15/01/2009 Withdrawn

Submitted by Anonymous (not verified) on 26 June 2024 - 16:30

Orphan designation: monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E (brentuximab vedotin) Treatment of Hodgkin's lymphoma, 15/01/2009 Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More